Submission Details
| 510(k) Number | K223538 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2022 |
| Decision Date | August 17, 2023 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223538 is an FDA 510(k) clearance for the Integrity Implant, a Mesh, Surgical, Non-absorbable, Orthopaedics, Reinforcement Of Tendon (Class II — Special Controls, product code OWX), submitted by Anika Therapeutics, Inc. (Beford, US). The FDA issued a Cleared decision on August 17, 2023, 267 days after receiving the submission on November 23, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 878.3300.
| 510(k) Number | K223538 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2022 |
| Decision Date | August 17, 2023 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | OWX — Mesh, Surgical, Non-absorbable, Orthopaedics, Reinforcement Of Tendon |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.3300 |
| Definition | For Reinforcement Of Soft Tissue Where Weakness Exists In Tendon Repair. |